AEON Biopharma, Inc. (AEON) vs Intensity Therapeutics Inc. (INTS)

AEON Biopharma, Inc. and Intensity Therapeutics Inc. are both Biotechnology companies. AEON Biopharma, Inc. and Intensity Therapeutics Inc. are of similar size ($12.7M and $12.7M). Across the 8 metrics below, Intensity Therapeutics Inc. leads on 5 and AEON Biopharma, Inc. on 3.

Valuation

Metric AEON INTS Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m 1.13 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (1,700.00%) (44.24%) (28.84%)
Free cash flow yield (103.87%) (85.91%) (23.03%)

Profitability

Metric AEON INTS Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 350.00% (195.88%) (57.72%)
Return on assets (621.70%) (139.85%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AEON INTS Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (105.42%) 70.74% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AEON INTS Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 0.54 5.00 4.73
Net debt to EBITDA (2.48) 0.99 0.96

Dividend

Metric AEON INTS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric AEON INTS Biotechnology median
Market cap 12.65m 12.70m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack